CT003

CT003 is a needle-free local anesthetic gel currently in preclinical development by Cessatech, a Danish pharmaceutical company specializing in pediatric pain management. The drug is specifically designed for application to open wounds, such as those encountered during pediatric laceration repair in emergency settings, to provide effective analgesia without the psychological and physical distress of needle-based administration. CT003 functions as a small molecule inhibitor that blocks voltage-gated sodium channels (Nav), thereby inhibiting nerve conduction and providing localized pain relief. It is being developed as a follow-on product to the company's lead asset, CT001, to address the unmet medical need for approved local anesthetic combinations suitable for direct application to open wounds in children.